Institute for Clinical Diabetology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
German Center for Diabetes Research (DZD), Partner Düsseldorf, München-Neuherberg, Germany.
Diabetologia. 2022 Mar;65(3):552-562. doi: 10.1007/s00125-021-05607-z. Epub 2021 Nov 20.
AIMS/HYPOTHESIS: In men with diabetes, the prevalence of erectile dysfunction increases with advanced age and longer diabetes duration and is substantially higher in men with type 2 diabetes than those with type 1 diabetes. This study aimed to evaluate the prevalence of erectile dysfunction among the five novel subgroups of recent-onset diabetes and determine the strength of associations between diabetes subgroups and erectile dysfunction.
A total of 351 men with recent-onset diabetes (<1 year) from the German Diabetes Study baseline cohort and 124 men without diabetes were included in this cross-sectional study. Erectile dysfunction was assessed with the International Index of Erectile Function (IIEF) questionnaire. Poisson regression models were used to estimate associations between diabetes subgroups (each subgroup tested against the four other subgroups as reference) and erectile dysfunction (dependent binary variable), adjusting for variables used to define diabetes subgroups, high-sensitivity C-reactive protein and depression.
The prevalence of erectile dysfunction was markedly higher in men with diabetes than in men without diabetes (23% vs 11%, p = 0.004). Among men with diabetes, the prevalence of erectile dysfunction was highest in men with severe insulin-resistant diabetes (SIRD) (52%), lowest in men with severe autoimmune diabetes (SAID) (7%), and intermediate in men with severe insulin-deficient diabetes (SIDD), mild obesity-related diabetes (MOD) and mild age-related diabetes (MARD) (31%, 18% and 29%, respectively). Men with SIRD had an adjusted RR of 1.93 (95% CI 1.04, 3.58) for prevalent erectile dysfunction (p = 0.038). Similarly, men with SIDD had an adjusted RR of 3.27 (95% CI 1.18, 9.10) (p = 0.023). In contrast, men with SAID and those with MARD had unadjusted RRs of 0.26 (95% CI 0.11, 0.58) (p = 0.001) and 1.52 (95% CI 1.04, 2.22) (p = 0.027), respectively. However, these associations did not remain statistically significant after adjustment.
CONCLUSIONS/INTERPRETATION: The high RRs for erectile dysfunction in men with recent-onset SIRD and SIDD point to both insulin resistance and insulin deficiency as major contributing factors to this complication, suggesting different mechanisms underlying erectile dysfunction in these subgroups.
目的/假设:在患有糖尿病的男性中,勃起功能障碍的患病率随着年龄的增长和糖尿病病程的延长而增加,并且在 2 型糖尿病男性中明显高于 1 型糖尿病男性。本研究旨在评估近期诊断的五种新型糖尿病亚组中勃起功能障碍的患病率,并确定糖尿病亚组与勃起功能障碍之间的关联强度。
本横断面研究共纳入来自德国糖尿病研究基线队列的 351 名近期诊断(<1 年)的男性糖尿病患者和 124 名无糖尿病的男性。采用国际勃起功能指数(IIEF)问卷评估勃起功能障碍。使用泊松回归模型估计糖尿病亚组(每个亚组与其他四个亚组作为参考进行比较)与勃起功能障碍(依赖二分类变量)之间的关联,调整用于定义糖尿病亚组的变量、高敏 C 反应蛋白和抑郁。
患有糖尿病的男性勃起功能障碍的患病率明显高于无糖尿病的男性(23% vs 11%,p=0.004)。在患有糖尿病的男性中,严重胰岛素抵抗性糖尿病(SIRD)患者勃起功能障碍的患病率最高(52%),严重自身免疫性糖尿病(SAID)患者最低(7%),严重胰岛素缺乏性糖尿病(SIDD)、轻度肥胖相关糖尿病(MOD)和轻度年龄相关性糖尿病(MARD)患者的患病率分别为 31%、18%和 29%。SIRD 男性调整后的 RR 为 1.93(95%CI 1.04,3.58),具有显著相关性(p=0.038)。同样,SIDD 男性的 RR 为 3.27(95%CI 1.18,9.10)(p=0.023)。相比之下,SAID 男性和 MARD 男性的未调整 RR 分别为 0.26(95%CI 0.11,0.58)(p=0.001)和 1.52(95%CI 1.04,2.22)(p=0.027)。然而,这些关联在调整后不再具有统计学意义。
结论/解释:近期 SIRD 和 SIDD 男性勃起功能障碍的高 RR 表明胰岛素抵抗和胰岛素缺乏是导致这种并发症的主要因素,这表明这些亚组中勃起功能障碍的潜在机制不同。